Jonathan Lancaster

4.7k total citations
19 papers, 800 citations indexed

About

Jonathan Lancaster is a scholar working on Reproductive Medicine, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Jonathan Lancaster has authored 19 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Reproductive Medicine, 6 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Jonathan Lancaster's work include Ovarian cancer diagnosis and treatment (5 papers), Genetic factors in colorectal cancer (3 papers) and BRCA gene mutations in cancer (2 papers). Jonathan Lancaster is often cited by papers focused on Ovarian cancer diagnosis and treatment (5 papers), Genetic factors in colorectal cancer (3 papers) and BRCA gene mutations in cancer (2 papers). Jonathan Lancaster collaborates with scholars based in United States, Austria and United Kingdom. Jonathan Lancaster's co-authors include Domenico Coppola, Thomas A. Sellers, Lili He, Xu Cx, Eric J. Richards, Jenny Permuth‐Wey, Jun Cheng, J Y Djeu, Sridevi Challa and Andrew Berchuck and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Jonathan Lancaster

18 papers receiving 786 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Lancaster United States 9 478 390 159 148 128 19 800
Won Duk Joo South Korea 16 264 0.6× 202 0.5× 55 0.3× 176 1.2× 150 1.2× 41 662
Lingmin Hu China 17 357 0.7× 187 0.5× 86 0.5× 86 0.6× 125 1.0× 46 845
Dorthe Gylling Crüger Denmark 15 275 0.6× 96 0.2× 122 0.8× 65 0.4× 185 1.4× 23 572
Hyo Pyo Lee South Korea 16 275 0.6× 167 0.4× 98 0.6× 111 0.8× 147 1.1× 44 763
Roland Matthews United States 17 269 0.6× 96 0.2× 83 0.5× 156 1.1× 162 1.3× 42 732
Sabine Preisler-Adams Germany 10 276 0.6× 216 0.6× 368 2.3× 39 0.3× 145 1.1× 16 687
Chi‐Mu Chuang Taiwan 13 386 0.8× 313 0.8× 43 0.3× 136 0.9× 185 1.4× 19 801
Anne‐Bine Skytte Denmark 14 154 0.3× 109 0.3× 243 1.5× 94 0.6× 94 0.7× 40 506
F. Ueland United States 13 202 0.4× 151 0.4× 146 0.9× 937 6.3× 187 1.5× 24 1.2k
Avishay Lahad Israel 10 246 0.5× 101 0.3× 323 2.0× 62 0.4× 50 0.4× 20 552

Countries citing papers authored by Jonathan Lancaster

Since Specialization
Citations

This map shows the geographic impact of Jonathan Lancaster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Lancaster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Lancaster more than expected).

Fields of papers citing papers by Jonathan Lancaster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Lancaster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Lancaster. The network helps show where Jonathan Lancaster may publish in the future.

Co-authorship network of co-authors of Jonathan Lancaster

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Lancaster. A scholar is included among the top collaborators of Jonathan Lancaster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Lancaster. Jonathan Lancaster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Lancaster, Jonathan. (2023). Public education is the great perpetuator. Phi Delta Kappan. 104(7). 54–57.
2.
Gormley, Mirinda Ann, Irene Pericot‐Valverde, Ashley Coleman, et al.. (2021). Effectiveness of peer recovery support services on stages of the opioid use disorder treatment cascade: A systematic review. Drug and Alcohol Dependence. 229(Pt B). 109123–109123. 44 indexed citations
3.
Filipits, Martin, M. Rudas, Richard Greil, et al.. (2019). Abstract P4-08-05: Prediction of distant recurrence using EndoPredict among women with ER-positive, HER2-negative breast cancer with a maximum follow-up of 16 years. Cancer Research. 79(4_Supplement). P4–8. 1 indexed citations
4.
Abbasi, Forough, Douglas C. Marchion, Yin Xiong, et al.. (2014). HSP90 inhibition decreases ovarian cancer cell proliferation and potentiates platinum sensitivity. Gynecologic Oncology. 133. 122–123. 4 indexed citations
5.
He, Lili, Eric J. Richards, Sridevi Challa, et al.. (2013). Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer. Oncogene. 33(6). 679–689. 341 indexed citations
6.
Apte, Sachin M., et al.. (2011). Phase II Trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12months of prior platinum-based chemotherapy. Gynecologic Oncology. 120. S83–S84. 2 indexed citations
7.
Goode, Ellen L., Matthew J. Maurer, Thomas A. Sellers, et al.. (2010). Inherited Determinants of Ovarian Cancer Survival. Clinical Cancer Research. 16(3). 995–1007. 44 indexed citations
8.
Hakim, Amy, H. John Barnes, Kenneth E. Anderson, et al.. (2009). Ovarian Adenocarcinomas in the Laying Hen and Women Share Similar Alterations in p53, ras, and HER-2/neu. Cancer Prevention Research. 2(2). 114–121. 65 indexed citations
9.
Quinn, Gwendolyn P., Susan T. Vadaparampil, Jungmee Lee, et al.. (2009). National survey of physicians practice patterns: Fertility preservation and cancer patients. Journal of Clinical Oncology. 27(18S). CRA9508–CRA9508. 2 indexed citations
10.
Quinn, Gwendolyn P., Susan T. Vadaparampil, Paul B. Jacobsen, et al.. (2009). National survey of physicians practice patterns: Fertility preservation and cancer patients. Journal of Clinical Oncology. 27(15_suppl). CRA9508–CRA9508. 8 indexed citations
11.
Chen, Yan, Bin Han, Lei Zhu, et al.. (2009). A Supervised SVD Approach to Ovarian Cancer Chemotherapy Response Prediction with Across Factor Normalization. 4234. 1–4. 1 indexed citations
12.
Quinn, Gwendolyn P., Susan T. Vadaparampil, Jungmee Lee, et al.. (2009). National survey of physicians practice patterns: Fertility preservation and cancer patients. Journal of Clinical Oncology. 27(18_suppl). CRA9508–CRA9508. 3 indexed citations
13.
Nasir, Aejaz, David Boulware, Hans Kaiser, et al.. (2007). Cyclooxygenase-2 (COX-2) expression in human endometrial carcinoma and precursor lesions and its possible use in cancer chemoprevention and therapy.. PubMed. 21(1). 35–43. 24 indexed citations
14.
Lancaster, Jonathan, Robyn Sayer, Carrie Blanchette, et al.. (2006). High expression of insulin-like growth factor binding protein–2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levels. International Journal of Gynecological Cancer. 16(4). 1529–1535. 28 indexed citations
15.
Li, Lihua, Li Chen, Dmitry B. Goldgof, et al.. (2005). Integration of Clinical Information and Gene Expression Profiles for Prediction of Chemo-Response for Ovarian Cancer. PubMed. 2005. 4818–21. 8 indexed citations
16.
Berchuck, Andrew, Michael E. Carney, Jonathan Lancaster, Jeffrey R. Marks, & P. Andrew Futreal. (1998). Familial Breast-Ovarian Cancer Syndromes. Clinical Obstetrics & Gynecology. 41(1). 157–166. 13 indexed citations
17.
Li, Chunde, Catharina Larsson, P. Andrew Futreal, et al.. (1998). Identification of two distinct deleted regions on chromosome 13 in prostate cancer. Oncogene. 16(4). 481–487. 74 indexed citations
18.
Berchuck, Andrew, Michael E. Carney, Jonathan Lancaster, et al.. (1998). Frequency of germline and somatic BRCA1 mutations in ovarian cancer.. PubMed. 4(10). 2433–7. 137 indexed citations
19.
Garvey, Fred K. & Jonathan Lancaster. (1957). The results of azo-gantrisin therapy in 228 patients with urinary tract infection.. PubMed. 18(2). 78–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Won Duk Joo Breakdown of academic impact, for papers by Lingmin Hu Breakdown of academic impact, for papers by Dorthe Gylling Crüger Breakdown of academic impact, for papers by Hyo Pyo Lee Breakdown of academic impact, for papers by Roland Matthews Breakdown of academic impact, for papers by Sabine Preisler-Adams Breakdown of academic impact, for papers by Chi‐Mu Chuang Breakdown of academic impact, for papers by Anne‐Bine Skytte Breakdown of academic impact, for papers by F. Ueland Breakdown of academic impact, for papers by Avishay Lahad
Rankless by CCL
2026